What to watch as Biogen presents its all-important Alzheimer's data

A few minutes on Thursday morning could decide Biogen's future. At a hotel along the San Diego Bay, researchers will present more details from a pair of clinical trials that tested the company's most prized Alzheimer's drug in patients with early stages of the disease.